Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive therapy with or without autologous bone marrow transplant for relapsed intermediate- and high-grade non-Hodgkin lymphoma
ISRCTN26449289Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Jan 1990
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, cisplatin, cytarabine, carmustine, etoposide and 1 more in non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Cancer Research UK. Started Jan 1990; status: completed.
02
Drugs
dexamethasonecisplatincytarabinecarmustineetoposide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on ISRCTN26449289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26449289.